ROTEM pilot study: A new method for measuring coagulation problems in women during labor.
Recruiting
- Conditions
- Hemorrhage post partumDUTCH: Haemorrhagia/Fluxus post partum
- Registration Number
- NL-OMON20305
- Lead Sponsor
- Dr. H.C.J. ScheepersPostbus 58006202 AZ Maastricht043-3874800hcj.scheepers@mumc.nl
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 200
Inclusion Criteria
1. Pregnant, > 24+0 weeks;
2. Age ≥ 18 years;
Exclusion Criteria
1. Labor < 24+0 weeks;
2. Prophylactic or therapeutic anticoagulant therapy (carbasalate calcium within the last 10 days or low molecular weight heparins within last 48 hours).
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. To obtain normal 'clotting' values through ROTEM® ante partum and in the post partum period;<br /><br>2. To validate these clotting values for pregnant women using conventional clotting tests as golden standard.<br>
- Secondary Outcome Measures
Name Time Method To evaluate whether the results of conventional clotting test or ROTEM can predict mild or severe HPP.